Director dealings: Smith & Nephew executives offload shares
Smith & Nephew
972.80p
16:39 20/12/24
Medical technology company Smith & Nephew disclosed two executive share sales on Wednesday, with its shares remaining flat after the announcement.
Equity Investment Instruments
12,067.95
17:14 20/12/24
FTSE 100
8,084.61
17:04 20/12/24
FTSE 250
20,450.69
17:14 20/12/24
FTSE 350
4,463.29
17:14 20/12/24
FTSE All-Share
4,421.11
17:04 20/12/24
Health Care Equipment & Services
10,620.84
17:14 20/12/24
NB Private Equity Partners Ltd.
1,554.00p
16:40 20/12/24
Phil Cowdy, its chief corporate development and corporate affairs officer, sold 12,083 shares on 27 April for £12.83280 each, resulting in a total value of £155,058.72.
Following the sale, Cowdy still held 49,000.99390 ordinary shares, equivalent to 0.00558% of its issued share capital.
Bradley Cannon, the company’s president of global orthopaedics, meanwhile sold 9,500 shares on 2 May at a price of £12.926813 apiece, resulting in a total value of £122,804.72.
After the transaction, Cannon still held 117,819.37494 shares, or 0.01342% of the firm’s issued capital.
Both individuals still maintained a shareholding in line with the company's guidelines after the sale, the board confirmed.
Elsewhere, NB Private Equity Partners saw its shares rise after non-executive director Trudi Clark made a small share purchase.
Clark purchased 1,247 shares at a price of 15.9p, for a total value of £19,827.30.
At 1427 BST, shares in Smith & Nephew were flat at 1,298p, while those in NB Private Equity Partners were up 1.69% at 120p.
Reporting by Josh White for Sharecast.com.